Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Target population for hypertensive therapy]

J P Boissel1

  • 1Unité pharmacoclinique, hôpital neurocardiologique, Lyon.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why a clinician may be interested and involved in computational medicine?

Progress in biophysics and molecular biology·2008
Same author

A global phenomenological model of ischemic stroke with stress on spreading depressions.

Progress in biophysics and molecular biology·2007
Same author

A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.

Journal of theoretical biology·2006
Same author

Low protein diets for chronic kidney disease in non diabetic adults.

The Cochrane database of systematic reviews·2006
Same author

Therapeutic objectives.

Evidence-based cardiovascular medicine·2005
Same author

[Intermittent claudications].

Journal des maladies vasculaires·2005
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Identifying individual patient responders to antihypertensive treatment is crucial for effective therapy. The INDANA project aims to create a comprehensive database for meta-analyses to personalize hypertension treatment by considering both benefits and risks.

Area of Science:

  • Clinical Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Biostatistics and Epidemiology

Context:

  • Current clinical trial data often fails to identify specific patient subgroups who benefit from antihypertensive treatments.
  • Undesirable secondary effects can make treatments inappropriate or harmful for certain individuals.
  • Personalized medicine approaches are needed to optimize therapeutic outcomes in hypertension management.

Purpose:

  • To develop a methodology for identifying responders to antihypertensive therapy using individual patient data.
  • To establish a comprehensive database integrating results from published preventive trials of antihypertensive therapy.
  • To conduct meta-analyses on individual patient parameters to understand factors influencing treatment response.

Summary:

Related Experiment Videos

  • The INDANA project aims to pool individual patient data from antihypertensive therapy trials.
  • Advanced meta-analysis techniques will be employed to identify demographic, sociological, and genetic factors influencing treatment efficacy.
  • This approach seeks to differentiate between patients who benefit from and those who do not respond to treatment, or may experience harm.

Impact:

  • Improved identification of patient responders to antihypertensive treatments.
  • Facilitation of individualized treatment strategies for hypertension based on predicted benefits and risks.
  • Potential to reduce adverse events and enhance the overall effectiveness of hypertension management.